Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine.
Heparin Active Pharmaceutical Ingredients Market contains market size and forecasts of Heparin Active Pharmaceutical Ingredients in global, including the following market information:
- Global Heparin Active Pharmaceutical Ingredients Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Heparin Active Pharmaceutical Ingredients Market Sales, 2017-2022, 2023-2028, (Kiloton)
- Global top five Heparin Active Pharmaceutical Ingredients companies in 2021 (%)
The global Heparin Active Pharmaceutical Ingredients market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
- The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
- Heparin Sodium Segment to Reach $ Million by 2028, with a % CAGR in next six years.
- The global key manufacturers of Heparin Active Pharmaceutical Ingredients include Hepalink, Changshan Pharm, Qianhong Bio-pharma, Opocrin, Pfizer, Aspen Oss, King-friend Biochemical Pharmaceutical, Bioibrica and Dongcheng Biochemicals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
- surveyed the Heparin Active Pharmaceutical Ingredients manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Heparin Active Pharmaceutical Ingredients Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Heparin Active Pharmaceutical Ingredients Market Segment Percentages, by Type, 2021 (%)
- Heparin Sodium
- Heparin Calcium
- Other
Global Heparin Active Pharmaceutical Ingredients Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Heparin Active Pharmaceutical Ingredients Market Segment Percentages, by Application, 2021 (%)
- Unfractionated Heparin
- Low Molecular Heparin
Global Heparin Active Pharmaceutical Ingredients Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Heparin Active Pharmaceutical Ingredients Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Heparin Active Pharmaceutical Ingredients revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Heparin Active Pharmaceutical Ingredients revenues share in global market, 2021 (%)
- Key companies Heparin Active Pharmaceutical Ingredients sales in global market, 2017-2022 (Estimated), (Kiloton)
- Key companies Heparin Active Pharmaceutical Ingredients sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Hepalink
- Changshan Pharm
- Qianhong Bio-pharma
- Opocrin
- Pfizer
- Aspen Oss
- King-friend Biochemical Pharmaceutical
- Bioibrica
- Dongcheng Biochemicals
- Jiulong Biochemicals
- Tiandong
- Xinbai
- Yino Pharma Limited
- Deebio
Industry Market Size
